Christy L. Shaffer, Director at Clearside Biomedical, Inc. (CLSD), bought 1,100 shares at $8.00 ($9K) on 2017-05-22, disclosed to the SEC on 2017-05-23.
Open-market purchase of $9k CLSD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| CLSD | BUY | 2017-03-22 | $15K | — | Filing → |
| ISPH | SELL | 2009-12-08 | $30K | — | Filing → |
| ISPH | SELL | 2009-08-25 | $60K | — | Filing → |